Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Plasma Tumor DNA and Pathologic Complete Response in Early-Stage, High-Risk Breast Cancer

NCT02743910 is registered in ClinicalTrials.gov with Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins as lead sponsor.

NCT NCT02743910
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02743910 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Plasma Tumor DNA and Pathologic Complete Response in Early-Stage, High-Risk Breast Cancer
Lead sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase
Observational
Overall status
Completed
Start date
July 31, 2016
Completion date
March 2, 2026
Enrollment
228 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer